Install
We provide information, research, news and interviews from the emergent psychedelic sector in one place.
- 4articles · 30d
- 3+ day agolatest article
- Aug 18, 2026earliest in window
- 75%with images
- 329avg words
- Medical 4
- Health & Wellness 3
- Health 2
- Arts, Culture, Entertainment & Media 1
- Business & Industrial 1
- Economy, Business & Finance 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Scoop: Johnson & Johnson to Lead Delix Therapeutics???? $85M Series C
3+ week, 5+ day ago (702+ words) 🎟️ Join us at The Psychedelic Business Forum in NYC Johnson & Johnson is set to lead neuroplastogen developer Delix Therapeutics’ $85M Series C round at a $190M pre-money valuation, according to documents reviewed by Psychedelic Alpha. Note: Audio versions of our articles are…...
Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development
3+ week, 5+ day ago (190+ words) 🎟️ Join us at The Psychedelic Business Forum in NYC This interview took place in May 2026. It has been edited for length and clarity. For the longest time, I felt there was something wrong with the idea that traditional antidepressants increase…...